CA2086698A1 - Derive de la pyridylsulfonyluree, ses procedes de preparation, et les compositions pharmaceutiques le contenant - Google Patents

Derive de la pyridylsulfonyluree, ses procedes de preparation, et les compositions pharmaceutiques le contenant

Info

Publication number
CA2086698A1
CA2086698A1 CA002086698A CA2086698A CA2086698A1 CA 2086698 A1 CA2086698 A1 CA 2086698A1 CA 002086698 A CA002086698 A CA 002086698A CA 2086698 A CA2086698 A CA 2086698A CA 2086698 A1 CA2086698 A1 CA 2086698A1
Authority
CA
Canada
Prior art keywords
compound
formula
pyrid
pharmaceutically acceptable
cycloheptylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002086698A
Other languages
English (en)
French (fr)
Inventor
Bernard Masereel
Bernard Pirotte
Marc Schynts
Jacques Delarge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2086698A1 publication Critical patent/CA2086698A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
CA002086698A 1992-01-06 1993-01-05 Derive de la pyridylsulfonyluree, ses procedes de preparation, et les compositions pharmaceutiques le contenant Abandoned CA2086698A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR92.00031 1992-01-06
FR9200031A FR2685917A1 (fr) 1992-01-06 1992-01-06 Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant.

Publications (1)

Publication Number Publication Date
CA2086698A1 true CA2086698A1 (fr) 1993-07-07

Family

ID=9425396

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002086698A Abandoned CA2086698A1 (fr) 1992-01-06 1993-01-05 Derive de la pyridylsulfonyluree, ses procedes de preparation, et les compositions pharmaceutiques le contenant

Country Status (8)

Country Link
US (1) US5391559A (enExample)
EP (1) EP0551219A1 (enExample)
JP (1) JPH0684353B2 (enExample)
AU (1) AU654607B2 (enExample)
CA (1) CA2086698A1 (enExample)
FR (1) FR2685917A1 (enExample)
NZ (1) NZ245619A (enExample)
ZA (1) ZA9364B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559151A (en) * 1994-11-30 1996-09-24 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
ITMI20022749A1 (it) * 2002-12-23 2004-06-24 Cosma S P A Nuovo procedimento per la sintesi della tosemide, in particolare della forma ii pura e stabile.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
FR2659080B1 (fr) * 1990-03-02 1994-07-08 Adir Nouveaux derives de la pyridylsulfonyluree et de la pyridylsulfonylthiouree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
JPH061766A (ja) 1994-01-11
JPH0684353B2 (ja) 1994-10-26
EP0551219A1 (fr) 1993-07-14
US5391559A (en) 1995-02-21
AU654607B2 (en) 1994-11-10
FR2685917B1 (enExample) 1995-06-02
FR2685917A1 (fr) 1993-07-09
AU3101593A (en) 1993-07-08
NZ245619A (en) 1994-10-26
ZA9364B (en) 1993-08-03

Similar Documents

Publication Publication Date Title
EP0580502B1 (fr) 3-(hydroxybenzylidényl)-indoline-2-ones, et les compositions pharmaceutiques qui les contiennent
EP0506539B1 (fr) Amides alkyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0684241B1 (fr) N-pyridyl carboxamides et dérivés, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
CA1213280A (fr) PROCEDE DE PREPARATION DE NOUVEAUX DERIVES DE 4-(1H- INDOL-3-YL) .alpha.-METHYL PIPERIDINE-1-ETHANOL ET DE LEURS SELS
CH643546A5 (fr) Procede pour la preparation de derives d'hydantoine.
EP1148881B1 (fr) UTILISATION DE DERIVES DE PYRIDAZINO ¬4,5-(b)|-INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
EP2231598B1 (fr) Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2659656A1 (fr) Derives de pyrimidinedione-2,4 et medicaments les contenant.
EP0312432B1 (fr) Dérivés du diméthyl-2,2 chromène, procédé d'obtention et compositions/pharmaceutiques en contenant
EP0109866B1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0566446B1 (fr) Dérivés d'indane-1, 3-dione et d'indane-1,2,3-trione, leurs procédés de préparation et leur application en thérapeutique
CA2086698A1 (fr) Derive de la pyridylsulfonyluree, ses procedes de preparation, et les compositions pharmaceutiques le contenant
EP0533516B1 (fr) Nouveaux composés amidiques des 1-(alcoxybenzyl) pipérazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent
EP0847999B1 (fr) Dérivés de N-benzylpipérazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP2917204B1 (fr) Derives de 1h-indole-3-carboxamide et leurs utilisation comme antagonistes du p2y12
EP0259206A1 (fr) Dérivés de la dihydro-1,4 pyridine leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
WO1998025913A1 (fr) Nouveaux derives [3h]-benzoxazole-2-thiones et [3h]-benzothiazole-2-thiones substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1757586B1 (fr) Nouveaux composés 1,1-pyridinylaminocyclopropanamines polysubstitués, leur procédé de préparation et les compositions pharmaceutiques yui les contiennent
CA2648836A1 (fr) Nouveaux derives d'1h-indol-1-yl uree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1954288A1 (fr) Derives d'amidine et leurs applications a titre de medicament
EP0406502B1 (fr) Procédé de préparation de la (-) [[(amino-2 éthoxy)-2 éthoxy]méthyl]-2 (dichloro-2,3 phényl)-4 éthoxycarbonyl-3 méthoxycarbonyl-5 méthyl-6 dihydro-1,4 pyridine, et intermédiaire pour sa préparation
EP0445039B1 (fr) Nouveaux dérivés de la pyridylsulfonylurée et de la pyridylsulfonylthiourée leur procédé de préparation et les compositions pharmaceutiques que les contiennent
EP0098204A1 (fr) Compositions thérapeutiques à base d'hydrazones N-substituées et nouvelles hydrazones N-substituées
CA2552827A1 (fr) Composes 1-1-pyridinyloxycyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
LU84067A1 (fr) Nouveau derive de la 2,4-dioxacyclohexanone,procede de sa preparation et medicaments le contenant

Legal Events

Date Code Title Description
FZDE Dead